相关实验视频
Updated: Jun 3, 2025

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
456
早期血栓激素改善了心脏手术后传播的血管内凝血
Kay Maeda1, Konosuke Sasaki1, Koyu Watanabe1
1Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Annals of thoracic surgery short reports
|January 10, 2025
概括
在心血管外科手术后,早期使用复合人体血栓模块素 (rhTM) 治疗扩散性血管内凝血 (DIC) 显著降低了30天死亡率. 及时的rhTM治疗改善了患者的治疗结果和DIC得分.
科学领域:
- 心血管外科心血管外科
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 分布式血管内凝血 (DIC) 是一种危及生命的术后并发症.
- 复合人体血栓模块素 (rhTM) 是一种潜在的DIC治疗方法,但其在心血管外科手术中的疗效尚未得到充分证实.
- 调查rhTM在治疗DIC心脏病后手术中的作用至关重要.
研究的目的:
- 评估rhTM在心血管手术后治疗DIC的疗效.
- 为了确定在这个患者群体中施用rhTM的最佳时间.
- 确定影响术后DIC患者死亡率的因素.
主要方法:
- 对27名心脏外科手术后的DIC患者进行了回顾性分析,他们接受了rhTM治疗.
- 评估DIC得分,实验室数据和主要并发症.
- 对30天全因死亡率和生存风险因素的评估.
主要成果:
- 在接受rhTM治疗的患者中,30天死亡率为51.9%.
- 在DIC诊断后5天或更晚的rhTM给药与较高的死亡率有关.
- 早期的rhTM治疗 (4天内) 改善了DIC得分和实验室标记 (CRP,血小板).
结论:
- 在DIC诊断后早期的rhTM给药与心血管外科手术患者的30天死亡率降低有关.
- 及时介入rhTM可能会改善术后DIC的临床和实验室结果.
- 对心血管手术患者最佳的rhTM治疗方案进行进一步的研究是有必要的.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K
Disorders of Hemostasis
696
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
696

